Shionogi & Co., Ltd
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company primarily focuses on metabolic syndrome, pain, infectious diseases, cholesterol medication, anti-hypertension drugs, depression treatment, prescription drugs, OTC drugs, and diagnostics. Its primary products include Cymbalta, a serotonin and noradrenaline reuptake inhibitor used for the treatment of depression, anxiety, diabetic neuropathic pain, fibromyalgia pain, chronic lower back pain, and osteoarthritis pain; Intuniv, a selective a2 adrenergic receptor agonist to treat attention-deficit hyperactivity disorder; Xofluza, an anti-influenza agent; and Symproic, a cancer pain analgesic tablet. It has a research collaborative agreement with National University Corporation Kyoto University to focus on drug discovery and medical research for the treatment of psychiatric disorders; strategic collaboration with Sage Therapeutics, Inc. to develop and commercialize SAGE-217 for MDD and other indications; license and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics Inc.; a strategic collaboration with Tetra Discovery Partners LLC for the clinical development and commercialization of BPN14770, a selective phosphodiesterase-4D allosteric inhibitor; a collaborative research agreement with PeptiDream Inc. for the discovery and development of a series of blood brain barrier penetrating peptide drug-conjugate; and strategic alliance with Tetra Therapeutics to develop and commercialize BPN14770 for the treatment of Alzheimer's disease, Fragile X syndrome, and other indications. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. Show More...
-
Website http://www.shionogi.co.jp
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 13.70 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share JPY 115.33 59.8 80.91 199.17 121.23 132.04 201.7 255.87 337.43 420.67 415.31 Dividends JPY 40.0 40.0 42.0 46.0 52.0 62.0 72.0 82.0 94.0 100.0 Payout Ratio % * 66.9 53.4 36.4 19.4 50.3 31.2 24.2 25.6 22.6 24.0 Shares Mil 335.0 335.0 335.0 335.0 335.0 334.0 331.0 328.0 323.0 316.0 311.0 Book Value Per Share * EUR 8.34 8.89 9.07 9.88 11.06 12.2 13.48 14.24 16.26 18.34 Free Cash Flow Per Share * EUR 1.15 0.79 1.15 0.92 1.06 1.25 2.25 1.92 3.73 Return on Assets % 7.41 3.76 5.18 12.16 7.21 7.42 10.73 12.81 15.63 17.69 17.42 Financial Leverage (Average) 1.58 1.59 1.52 1.37 1.25 1.27 1.25 1.28 1.2 1.17 1.11 Return on Equity % 11.86 5.98 8.06 17.46 9.41 9.34 13.55 16.25 19.37 20.92 19.61 Return on Invested Capital % 8.89 4.6 6.35 14.52 8.54 8.75 12.7 15.28 18.18 20.52 19.32 Interest Coverage 35.95 23.42 32.2 52.92 74.05 300.46 471.78 558.7 247.64 294.19 429.49 Current Ratio 3.75 3.21 2.94 2.72 3.22 3.83 4.38 3.79 5.39 5.18 7.76 Quick Ratio 2.75 2.33 2.08 1.77 2.27 2.66 3.37 2.93 4.38 4.41 6.48 Debt/Equity 0.31 0.28 0.2 0.07 0.02 0.06 0.05 0.06 0.03